Anika Therapeutics
Price & Volume
Stats
See more52W Range | $7.87-$25.63 |
Market Cap | $135.8M |
Shares Short | 360,119 |
Financials
See moreRevenue (12 Mos) | $114.5M |
Revenue Growth (YoY) | -8.2% |
Gross Profit (12 Mos) | $66.1M |
Diluted EPS | -$0.90 |
News
See moreYahoo Finance • yesterday
ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders
Yahoo Finance • 7 days ago
Notable Friday Option Activity: SIRI, BTBT, FCX
Yahoo Finance • 15 days ago
ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm
Yahoo Finance • 30 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
About
CEO | Dr. Cheryl Renee Blanchard Ph.D. |
CFO | Mr. Stephen D. Griffin |
Address | 32 Wiggins Avenue, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 288 |
